Difficulty: Medium
Average Score: 73%
Practice
A young patient comes with progressive cognitive decline, a personality disorder, and chorea. He gets diagnosed with a neurodegenerative disorder. A CT scan showed atrophy of the head of the caudate nucleus. Which neurotransmitter is involved in the disorder?
Correct answer
D
Rationale
In this scenario, the correct answer is D) None of these. The neurodegenerative disorder being described is Huntington's disease. The neurotransmitter involved in Huntington's disease is dopamine. Dopamine plays a crucial role in motor function and cognition, and its dysfunction is linked to the symptoms observed in this patient, such as chorea and cognitive decline.
Option A) 5-hydroxytryptamine, also known as serotonin, is not the neurotransmitter primarily affected in Huntington's disease. While serotonin abnormalities can impact mood and behavior, it is not the key neurotransmitter associated with this specific neurodegenerative disorder.
Option B) Acetylcholine is not the neurotransmitter primarily involved in Huntington's disease. Acetylcholine is implicated in conditions like Alzheimer's disease, where its levels are reduced, leading to cognitive decline. However, it is not the neurotransmitter linked to the symptoms described in this case.
Option C) Norepinephrine is not the neurotransmitter primarily affected in Huntington's disease. Norepinephrine is involved in the body's stress response and has roles in attention, mood, and arousal. While norepinephrine abnormalities can contribute to certain psychiatric conditions, it is not the neurotransmitter central to Huntington's disease.
Understanding the neurotransmitter involvement in neurodegenerative disorders is crucial for healthcare professionals, especially in diagnosing and managing these conditions. This knowledge helps in selecting appropriate treatment strategies and improving patient outcomes through targeted interventions based on the underlying pathophysiology.
Option A) 5-hydroxytryptamine, also known as serotonin, is not the neurotransmitter primarily affected in Huntington's disease. While serotonin abnormalities can impact mood and behavior, it is not the key neurotransmitter associated with this specific neurodegenerative disorder.
Option B) Acetylcholine is not the neurotransmitter primarily involved in Huntington's disease. Acetylcholine is implicated in conditions like Alzheimer's disease, where its levels are reduced, leading to cognitive decline. However, it is not the neurotransmitter linked to the symptoms described in this case.
Option C) Norepinephrine is not the neurotransmitter primarily affected in Huntington's disease. Norepinephrine is involved in the body's stress response and has roles in attention, mood, and arousal. While norepinephrine abnormalities can contribute to certain psychiatric conditions, it is not the neurotransmitter central to Huntington's disease.
Understanding the neurotransmitter involvement in neurodegenerative disorders is crucial for healthcare professionals, especially in diagnosing and managing these conditions. This knowledge helps in selecting appropriate treatment strategies and improving patient outcomes through targeted interventions based on the underlying pathophysiology.